Mikail, Nidaa
Rossi, Alexia
Bengs, Susan
Haider, Ahmed
Stähli, Barbara E.
Portmann, Angela
Imperiale, Alessio
Treyer, Valerie
Meisel, Alexander
Pazhenkottil, Aju P.
Messerli, Michael
Regitz-Zagrosek, Vera
Kaufmann, Philipp A.
Buechel, Ronny R.
Gebhard, Cathérine http://orcid.org/0000-0001-7240-5822
Funding for this research was provided by:
University of Zurich
Article History
Received: 4 May 2022
Accepted: 12 July 2022
First Online: 17 August 2022
Declarations
:
: All authors have the following to disclose: The University Hospital of Zurich holds a research contract with GE Healthcare. CG has received research grants from the Novartis Foundation, Switzerland. AM has provided a consulting, advisory, or speaker role for Amgen, Astellas, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Gerresheimer, GSK, Janssen, Merck, MSD, Novartis, Roche, Sanofi, Servier, Takeda and Vifor, has received research funding from Bayer, Sanofi, Gerresheimer (personal), and Merck & Cie (institutional), has intellectual property interests relating to Merck & Cie (not related to this report), has been paid to provide expert testimony for Sanofi, and has reported travel/accommodation expenses paid for by Amgen, Astellas, Boehringer Ingelheim, Janssen, Merck, Roche, Sanofi, and Servier. BS and her research have been supported by the H.H. Sheikh Khalifa bin Hamad Al-Thani Research Programme, and research grants to the institution from the OPO Foundation, the Iten-Kohaut Foundation, the German Center for Cardiovascular Research (DZHK), Boston Scientific, and Edwards Lifesciences. BS has received consulting and speaker fees from Boston Scientific, Abbott Vascular, and MedAlliance.